Skip to content
10-Q

Quarterly Report

SELLAS Life Sciences Group, Inc. SLS

0001390478-25-000016

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 105.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 98.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 93.19M sh
Shares Diluted Q2 2025 · Jun 30, 2024 57.63M sh
Shares Diluted Q2 2025 · Jun 30, 2024 51.22M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$16.4M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$20.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $25.3M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $13.89M
Stockholders Equity Q2 2025 · Jun 30, 2025 $26.15M
Stockholders Equity Q2 2025 · Mar 31, 2025 $27.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $9.47M
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.91M
Stockholders Equity Q2 2025 · Mar 31, 2024 $9.68M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$7.98M
Current Liabilities Q2 2025 · Jun 30, 2025 $6M
Current Liabilities Q2 2025 · Dec 31, 2024 $9.51M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.16M
Total Liabilities Q2 2025 · Dec 31, 2024 $9.97M
Current Assets Q2 2025 · Jun 30, 2025 $29.45M
Current Assets Q2 2025 · Dec 31, 2024 $16.33M
Total Assets Q2 2025 · Jun 30, 2025 $32.31M
Total Assets Q2 2025 · Dec 31, 2024 $19.43M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.33
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic Q2 2025 · Jun 30, 2025 −$0.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.33
Sga Expense Q2 2025 · Jun 30, 2025 $3M
Sga Expense Q2 2025 · Jun 30, 2025 $5.86M
Sga Expense Q2 2025 · Jun 30, 2024 $2.44M
Sga Expense Q2 2025 · Jun 30, 2024 $6.97M
Net Income Q2 2025 · Jun 30, 2025 −$6.6M
Net Income Q2 2025 · Jun 30, 2025 −$12.41M
Net Income Q2 2025 · Jun 30, 2024 −$7.47M
Net Income Q2 2025 · Jun 30, 2024 −$17.04M
Operating Income Q2 2025 · Jun 30, 2025 −$6.87M
Operating Income Q2 2025 · Jun 30, 2025 −$12.94M
Operating Income Q2 2025 · Jun 30, 2024 −$7.62M
Operating Income Q2 2025 · Jun 30, 2024 −$17.27M